If the idea of direct infusion of HDL turns out to have merit, I would expect a non-plasma-derived product to be more marketable as long as the production cost is not excessive.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.